Calidi Biotherapeutics Inc (AMEX:CLDI)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 1.03. At the close of trading, the stock’s price was $0.74, to imply a decrease of -6.32% or -$0.05 in intraday trading. The CLDI share’s 52-week high remains $8.30, putting it -1021.62% down since that peak but still an impressive 21.62% since price per share fell to its 52-week low of $0.58. The company has a valuation of $19.30M, with an average of 0.35 million shares in intraday trading volume over the past 10 days and average of 1.50 million shares over the past 3 months.
Calidi Biotherapeutics Inc (AMEX:CLDI) trade information
After registering a -6.32% downside in the last session, Calidi Biotherapeutics Inc (CLDI) has traded red over the past five days. The 5-day price performance for the stock is -12.93%, and -41.26% over 30 days. With these gigs, the year-to-date price performance is -35.64%. Short interest in Calidi Biotherapeutics Inc (AMEX:CLDI) saw shorts transact 0.78 million shares and set a 0.31 days time to cover.
The extremes give us $2 and $9 for target low and target high price respectively. As such, CLDI has been trading -1116.22% off suggested target high and -170.27% from its likely low.
CLDI Dividends
Calidi Biotherapeutics Inc has its next earnings report out on 2024-Nov-11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Calidi Biotherapeutics Inc (AMEX:CLDI)’s Major holders
Calidi Biotherapeutics Inc insiders hold 7.88% of total outstanding shares, with institutional holders owning 4.06% of the shares at 4.41% float percentage. In total, 4.06% institutions holds shares in the company, led by RED WAVE INVESTMENTS LLC. As of 2024-06-30, the company held over 0.62 million shares (or 1.1723% of shares), all amounting to roughly $0.12 million.
The next major institution holding the largest number of shares is CPR INVESTMENTS INC. with 0.56 million shares, or about 1.0511% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.11 million.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Calidi Biotherapeutics Inc (CLDI) shares. Going by data provided on Dec 31, 2024 , Fidelity Extended Market Index Fund holds roughly 92.51 shares. This is just over 0.33% of the total shares, with a market valuation of $68469.0. Data from the same date shows that the other fund manager holds a little less at 61.37, or 0.22% of the shares, all valued at about 45422.0.
